Methods: Forty-three septic shock patients who were undergoing early goal-directed therapy resuscitated within 24 h were enrolled. The patients were randomly divided into the midazolam group and the propofol group. An initial passive leg-raising test (PLR1) was performed to evaluate passive leg raising test (PLR) responsiveness. Then, the patients were infused with midazolam or propofol. After increasing the doses of the sedatives to titrate to a Ramsay 4 score, a second passive leg raising test (PLR2) was conducted to evaluate PLR responsiveness. The primary end-point was the preload dependency before and after sedation with midazolam or propofol.
1.

Introduction
Volume expansion is commonly used in critically ill patients to improve their hemodynamic conditions, which is based on their volume responsivity. In a previous report, fewer than 50% of the patients responded to the volume expansion that was deemed necessary by the clinicians [1] . In other studies, exacerbated pulmonary edema and septic shock concurrent with an increased extravascular lung water index caused significant challenges to the lifesaving procedures in preload unresponsive patients [2, 3] . Therefore, it is of prime importance to improve the preload dependency of septic shock patients.
Infection, trauma, pain, a prolonged mechanical ventilation time, and/or septic shock forces critically ill patients into a state of severe stress, which can contribute to myocardial ischemia, arrhythmia, gastrointestinal tract ischemia, and stress ulcers. In addition, catecholamine (CA) levels are markedly increased in severe stress reactions in the intensive care unit (ICU) setting [4] . As CA is able to attenuate the preload dependency of the heart in patients [5] , we speculated that a decreased preload dependency may exist in those with a severe stress reaction.
Currently, propofol and midazolam are the most widely used drugs for the sedation of patients in the ICU [6, 7] . As blocking agents for the sympathetic nervous system, they can inhibit the activity of the autonomic nervous system [8, 9] . Sedation can attenuate the release of CA in vivo [10, 11] leading to remarkable decreases in the stress reaction caused by noxious stimulation as well as potential decreases in the cardiac preload and peripheral resistance. In our previous observational study [12] , we confirmed that a propofol infusion, but not a dexmedetomidine infusion, can increase the preload dependency in circulatory failure patients. Nevertheless, the study included pooled septic and nonseptic patients. The effect of sedative drugs on preload dependency in septic shock patients remains unclear. The vascular tone and the ability to respond to drugs in septic shock are different compared with nonseptic shock conditions because of vasoparesis. Forty-three patients with the clinical manifestations of septic shock were included in this study. A passive leg raising test (PLR) test was performed to evaluate the patients' cardiac preload dependency before and after increasing the sedation level (using propofol or midazolam) from a Ramsay score 3 to a Ramsay score 4.
Methods
Patients
Forty-three septic shock patients admitted to the ICU from May 2012eMay 2013 were included in this prospective, nonblinded, randomized, controlled study. (1) aged <18 y; (2) an intra-abdominal pressure of >12 mm Hg; (3) a central nervous system pathology; (4) a second-degree heart blockage or third-degree heart blockage, bradycardia, heart blockage, acute coronary syndrome, cardiac shock, or use of intra-aortic balloon pump; (5) contraindications to PLR, such as a craniocerebral injury and venous thrombosis; (6) severe liver disease (ChildePugh class C); or (7) a systolic blood pressure of <90 mm Hg despite vasopressor infusion.
Measurements
An opiate drug was administered to induce analgesia before the study. No modulation was performed in the doses of the vasoactive agent and analgesics, respirator parameters, and fluid infusion rate. The patients were monitored by CVP measurements, using an invasive arterial pressure and a PiCCO 2 (Pulsion Medical Systems, Munich, Germany) device. Previous studies have confirmed the utility of PiCCO measurements for assessing the preload dependency in septic shock patients [5, 14] . The cardiac output (CO) and stroke volume were determined with a PiCCO 2 device and measured by transpulmonary thermodilution before and after the study drug (propofol or midazolam) infusion and by a pulse contour analysis before and after the PLR tests. The maximal pressure developed by the left ventricle (dP/dtmax) and global end-diastolic volume (GEDI) index were determined with the PiCCO 2 device.
Study design
An initial PLR test (PLR1) was performed in all the patients to evaluate the preload dependency at baseline. PLR was performed by transferring the patients from a semirecumbent position to a horizontal position with the legs elevated at 45 [12] . Propofol and midazolam were infused and titrated according to the Ramsay scale; the goal of the sedation was to increase the sedation level from Ramsay score 3 to Ramsay score 4. Preload dependency was assessed by a PLR test according to the previously documented methods [5] . A patient was considered to have a positive PLR test finding if the change in the cardiac function index (CI) induced by the PLR increased by !10% during the PLR test [5] . An initial bolus dose of 0.05 mg/kg of midazolam, followed by a continuous infusion with 0.05e0.1 mg/kg/h or an initial bolus dose of 0.5 mg/ kg propofol, and then continuous infusion with 0.5e2.0 mg/ kg/h was administered. The infusion rate of the propofol or midazolam was titrated to maintain the target sedation depth of Ramsay score 4. After 40 min, when a suitable sedation level was achieved and the hemodynamic variables were stabilized, a second PLR test (PLR2) was then performed. Treatment
methods for hypotension were followed; that is, when a systolic blood pressure of <80 mm Hg or a 30% decrease from the baseline [7] was observed, a bolus of intravenous fluid was administered, the sedative drug infusion was interrupted, and vasoactive agents were administered if needed.
Statistical analysis
The data are expressed as the mean AE standard deviation or as the median (25%e75% interquartile range), as appropriate. The statistical analysis was performed by a two-way repeated measurements analysis of variance. A Bonferroni correction was applied in the case of multiple post hoc pairwise comparisons. The data were compared between the different propofol and midazolam groups of patients using a twosample Student t-test, ManneWhitney U test, or Fisher exact test, as appropriate. The power of the study was a posteriori calculated to be 80% for evidencing a 10% decrease in CO of Ramsay score 3. A P value < 0.05 was considered significant. We conducted the statistical analyses using the SPSS 16.0 software package (SPSS Inc, Chicago, IL).
Results
Patient characteristics
Seven hundred twenty-four patients were screened, of whom 125 patients were diagnosed with septic shock. Of these, 82 patients were excluded because of severe cardiac dysfunction (27%), unconsciousness with central nervous system pathology (13%), contraindications for PLR or unstable hemodynamics (e.g., an SBP of <90 mm Hg despite vasopressor infusion (25%)), or who met other exclusion criteria, such as the PiCCO or central venous catheters being unavailable (12%) or an inability to achieve EGDT before the sedative drugs were used (25%). Forty-three septic shock patients were enrolled in this study. The patients were divided into two groups as follows: the midazolam group (n ¼ 21) and the propofol group (n ¼ 22). The patient characteristics are summarized in Table 1 . There were no statistically significant differences in the clinical characteristics, background medical therapy, or 28-d mortality between these groups. In addition, there were no statistically significant differences in the time before inclusion from the EGDT achieved or in the total fluid balance before inclusion. In the midazolam group, the patients were divided into two groups at baseline according to preload dependency as follows: a positive PLR1 group (n ¼ 9) and a negative PLR1 group (n ¼ 12). In the propofol group, the patients were divided into two groups at baseline according to their preload dependency as follows: a positive PLR1 group (n ¼ 8) and a negative PLR1 group (n ¼ 14).
Changes in hemodynamic variables on sedation with propofol or midazolam
Propofol was administered as a bolus dose of 30 (interquartile range: 30e35 mg) and was continuously infused at 50 mg h À1 (interquartile range: 33e60). Midazolam was administered as a bolus dose of 2.5 (interquartile range: 2.0e3.0 mg) 
and continuously infused at 1.5 mg h À1 (interquartile range: 1.2e2.0). No significant difference was observed in the dose of propofol or midazolam in the subgroups of patients with negative or positive PLR1 tests. There were significant decreases in the heart rate and CI after propofol or midazolam sedation (both P < 0.01). There were no differences between the two groups. No significant decreases in the CVP, mean arterial pressure, stroke volume index, systemic vascular resistance index, dp/max, and GEDI were observed after the propofol or midazolam sedation (Table 2 ).
3.3.
The effects of sedation with propofol or midazolam on preload dependency There were no significant differences in the PLR-D CI in the midazolam group compared within the propofol group at baseline. The analysis was carried out according to whether the PLR1 was positive. In the midazolam-PLR1-negative patients, there was no difference between the PLR1-D CI and the PLR2-D CI (þ1.4% AE 7.4% versus þ1.7% AE 6.4%, P > 0.05). Additionally, in the midazolam-PLR1-positive patients, there was no difference between the PLR1-D CI and the PLR2-D CI (þ19.9% AE 8.4% versus þ18.6% AE 12.6%, P > 0.05). By contrast, in the propofol-PLR1-negative patients, there was a significant increase in the PLR-D CI after sedation to Ramsay 4 score compared with Ramsay 3 score (þ7.3% AE 4.8% versus þ3.2% AE 4.7%, P ¼ 0.008). There was no significant difference between the PLR1-D CI and the PLR2-D CI (þ22.0% AE 6.5% versus þ16.5% AE 6.5%, P > 0.05) in the propofol-PLR1-positive patients (Figure) .
Discussion
In this study, we investigated the effects on preload dependency of propofol and midazolam in septic shock patients. Our results indicated the following: (1) a remarkable decrease in CO was induced after propofol or midazolam infusion in these patients and (2) remarkable changes in CI were noted after propofol but not midazolam infusion during the PLR2 compared with those obtained after the PLR1 in the subgroups patients with a negative PLR1 test, which demonstrated that the preload dependency among the patients with propofol infusion (sedation change to Ramsey score 4) was enhanced.
The effects of propofol on the cardiac preload dependency
The influence of propofol on the systemic circulation in critically ill patients has not been well defined. As a short-acting, intravenously administered hypnotic agent that can inhibit the function of the central nervous system through the potentiation of gamma-amino-butyric acid receptor activity, propofol has been commonly used for the induction and maintenance of general anesthesia since 1980. However, propofol can attenuate the release of CA in vivo, resulting in a decrease in the cardiac preload [9] . In our study, after propofol infusion, a significant difference was noted in the hemodynamics. No significant difference was noted in the cardiac contractility. Nevertheless, a significant decrease in the arterial blood pressure was observed because of angiotasis and decreased venous return [15e19]. In our study, no significant decrease was observed in CVP after propofol infusion. In addition, a remarkable preload dependency increase was noted after the sedation level increase from Ramsay score 3 to Ramsay score 4 among the PLR-negative patients in the propofol subgroups. According to a previous report, propofol causes a direct relaxation of both the venous and arterial tissue, with the venous effects occurring at a lower propofol concentration. Moreover, further evidence has indicated that clinically relevant concentrations of propofol do not induce direct artery vasodilator effects [20] .
Although we cannot determine the stressed and unstressed volumes directly, our results have demonstrated a partial transfer from the stressed to the unstressed volume, that is, a large reserve of unstressed volume was formed to maintain the vascular filling pressure [21] . In addition, the relaxation of the venous blood vessels in the patients with a preload dependency was significantly different from those without. These results indicated that obvious vasodilatation was induced in the patients with a preload dependency after propofol infusion. This effect should be given close attention during the resuscitation of septic shock patients. We speculate that this effect might be associated with the venous blood flow recruited during the PLR2 caused by the propofol-induced vasodilatation, which is in contrast with the vasoconstrictive effects caused by noradrenaline. Moreover, an alteration of 
the dependent pattern of the heart on a preload was caused by propofol.
The effects of midazolam on cardiac preload dependency
Midazolam had less of an effect on the cardiac preload although it had certain vasodilation effects. Midazolam is a water-soluble benzodiazepine with a rapid onset of action and a short elimination half-life; in addition, midazolam does not have active metabolites and an adrenal steroidogenesis inhibitory effect [22] . Thus, it may be a good sedative drug of choice to decrease mortality in adults with refractory status epilepticus [23] . Currently, it is widely used in the ICU because of its own favorable properties [6, 7] . In our unit, midazolam is usually used as a continuous intravenous infusion followed by a bolus dose for short-term sedation. Used in this way, an adequate sedation level (Ramsay score 4) is quickly achieved that is neither too deep nor inadequate.
In the present study, midazolam did not increase preload dependency as assessed by the PLR2-D CI in septic shock patients with an increased sedation level from Ramsay score 3 to Ramsay score 4. This result most likely occurred because midazolam did not alter the cardiac preload significantly, as indicated by the CVP and GEDI surrogates in these patients. Another possible reason is that the patients included into the study were patients with septic shock, whose blood vessels were already paralyzed; thus, the weak vasodilation effect of midazolam would have been unable to dilate the blood vessels significantly or lead to a significant cardiac preload decrease. Furthermore, midazolam infusion did not change the cardiac function, as indicated by dP/dtmax; as a result, preload dependency did not increase markedly, although the venous return (as shown by the CO) decreased somewhat from baseline. These hemodynamic effects are different from an animal study that used a large dose [24] from healthy patients undergoing anaesthesia [25] .
Clinical implications
Our study indicates that sedation can also impact preload dependency. Our study was conducted in a postseptic shock clinical setting consistent with the way that patients are often received, which includes fluid resuscitation and/or CA; thus, the similar effect that propofol or midazolam induced could be expected in clinical use.
In the present study, only a slight decrease in CO in the patients after propofol or midazolam infusion was observed. This result is particularly important to emphasize in patients with septic shock because no further decrease in tissue oxygen delivery occurs after infusion. A previous study has shown that propofol or midazolam infusion for sedation preserved the hemodynamics in critically ill patients after coronary artery bypass grafting [26] . Therefore, one might expect that propofol or midazolam could be used safely in patients' septic shock, which may already present with cardiac injury because such treatment may result in good hemodynamic tolerance.
Volume expansion is critical for the appropriate treatment of patients with hemodynamic compromise. In addition, nondiscriminate fluid administration has the potential to induce or exacerbate pulmonary edema and fluid overload, particularly in patients with sepsis [2, 3] . An adequate preload dependency is critical for critically ill patients with clinical evidence of insufficient organ perfusion pressure. The preload dependency of intensive care patients can be altered by the general state of stress and high CA levels [5] .
Most importantly, we found that preload dependency increased after a suitable sedation with propofol infusion; this treatment may benefit patients with septic shock with a nonpreload dependency because fluid administration guided by fluid responsiveness in critically ill patients is a matter of fundamental importance for survival in cases involving septic shock. This effect should be of particular importance during the resuscitation of patients with circulatory failure.
Limitations
The limitations of our study were as follows: (1) we cannot conclude that midazolam cannot enhance the preload dependency as we only investigated the sedation level starting from Ramsay score 3 to Ramsay score 4 in this study. Because Ramsay score 4 is commonly used in the clinical setting, if the sedation score were to have increased to 5 or more, the results may have differed. (2) All the patients included in this study received propofol, an opiate or an analog administered before being included in the study to achieve the targeted baseline level of sedation in the pooled studies and to facilitate the PLR test and the PiCCO measurements. The patients in the two groups crossed over between propofol and midazolam treatment groups, reducing the power of the study drug to demonstrate any potential benefits of the increased cardiac preload dependency. Thus, our results may not be generalizable. (3) Only short-term hemodynamics were determined in this study. Although no significant difference was noted in the mortality among the patients with propofol or midazolam sedation, we cannot determine the effects of the preload dependency enhancement by propofol on the mortality and patient outcome.
Conclusions
In septic patients with a negative PLR test at baseline and with an increased sedation depth from Ramsay score 3 to Ramsay score 4, propofol but not midazolam increased cardiac preload dependency, as assessed by a PLR test.
